Contera Pharma (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Registration number:
33062214
Category:
Biotech
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

M&A and Exit deals (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Contera Pharma is a Danish clinical stage biotech company focusing on discovery and development of new innovative drugs for treatment of movement disorders for which there is a high unmet medical need.

Companies with similar profile to Contera Pharma:

CompanyCriteria
Sweden Scandinavian Real Hearts
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Desentum
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland BioMensio
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acesion Pharma
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland MetGen
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark BioPhero
43%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Ilya Pharma
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark RSP Systems
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Cytovac
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Iceland Alvotech
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Planktonic
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Bioreperia
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway SonoClear
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Mobidiag
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Aprea Therapeutics
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Saga Diagnostics
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Cytovation
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark NMD Pharma
33%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes